FGFR1 and breast carcinoma: The addition of VEGFR1 inhibitors solved the limited practical effects of FGFR inhibitors in FGFR1-amplified breast cancers through blocking the contribution of FGFR1 to VEGF secretion (Golfmann et al., 2018).